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Summary
Background.— Vagal hyperreactivity (VHR) is a frequent etiology of infant fainting spells; but
it is sometimes difﬁcult to diagnose. A biochemical test would therefore be useful, especially
as the oculocardiac reﬂex (OCR) test innocuity is not absolute.
Aims.— To evaluate urinary excretions of norepinephrine, epinephrine and dopamine as markers
for vagal hyperreactivity.
Methods.— During check-up of 55 infants from 0.5 to 11months of age, for discomfort episodes,
including OCR and Holter recording, 24 h urinary assays of total norepinephrine, epinephrine
and dopamine were carried out to evaluate sympathetic activity.
Results.— Epinephrine and norepinephrine urinary excretions were negatively correlated with
VHR intensity, as measured by the OCR ECG parameters: RRmax, % cardiac deceleration and
minimal frequency; dopamine excretion was not. When RRmaxOCR was greater or equal to
800ms, epinephrine urinary excretion tended to be less or equal to 9 nmol/mmol creatinine
and norepinephrine excretion less or equal to 190 nmol/mmol creatinine.
Conclusion.— A delay in maturation of the sympathetic system and/or adrenomedullary glands
with low secretion of norepinephrine and epinephrine inducing a desequilibrium of the sym-
pathetic/parasympathetic balance may contribute to the fainting spells observed with VHR.
Epinephrine and norepinephrine urinary excretions may provide informative complementary
noninvasive markers for VHR.
© 2010 Elsevier Masson SAS. All rights reserved.
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Résumé
Justiﬁcation.— L’hyperréactivité vagale (HRV) est une étiologie fréquente des malaises chez le
nourrisson; son diagnostic est parfois difﬁcile. Un test biochimique serait donc utile, d’autant
que l’innocuité de l’épreuve du reﬂexe oculocardiaque (ROC) n’est pas absolue.
Objectif.— Répondre à la question: les excrétions urinaires de noradrénaline, adrénaline et
dopamine sont-elles marqueurs d’HRV ?
Méthodes.— Les excrétions urinaires de noradrénaline, adrénaline et dopamine totales de
24 heures ont été mesurées pour évaluer l’activité sympathique chez 55 nourrissons de 0,5 à
11mois présentant des malaises et soumis au bilan habituel clinique et électrocardiographique
incluant le ROC et l’enregistrement Holter de 24 heures.
Résultats.— Les excrétions urinaires d’adrénaline et noradrénaline sont négativement cor-
rélées avec l’intensité d’HRV appréciée par les paramètres électrocardiographiques du ROC:
RRmax, pourcentage de décélération et fréquence minimale cardiaques. Lorsque RRmax au ROC
est supérieur ou égal à 800ms, l’excrétion nycthémérale d’adrénaline tend à être inférieure ou
égale à 9 nmol/mmol de créatinine, celle de noradrénaline inférieure ou égale à 190 nmol/mmol
de créatinine.
Conclusion.— Un retard de maturation du système sympathique et/ou des médullosurrénales
avec hyposécrétion de noradrénaline et d’adrénaline entraînant un déséquilibre de la bal-
ance parasympathique/sympathique pourrait contribuer aux malaises associés à une HRV. Les
excrétions nycthémérales d’adrénaline et noradrénaline pourraient constituer des marqueurs
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Introduction
Vagal hyperreactivity (VHR) is a frequent etiology in infant
fainting spells or in apparent life threatening events (ALTE).
It appears isolated, without any other cause of fainting spell,
in about 12 to 15% of all cases [1]. It is more frequently found
in association with gastro-esophagal reﬂux. VHR is also asso-
ciated with reﬂex anoxic seizures (white breath-holding) [2].
It is suspected to participate in the etiology of sudden infants
death syndrome (SIDS) [3—7].
Even though VHR is that frequent and systematically
investigated for infant discomfort evaluation in our cen-
tre of infant cardiology, it is still difﬁcult to diagnose and
even controversial. Diagnosis relies on a stack of clinical,
s
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inon invasifs d’HRV.
s droits réservés.
istorical and electrocardiographic arguments. Two comple-
entary tests currently used for that purpose in infants are
culocardiac reﬂex (OCR) and 24-h Holter ECG [4,6,7]. But
ormal limits for these two tests, particularly for OCR, are
iscussed and falsely negative results were reported with
econdary evidence of VHR [4]. Furthermore, the innocu-
ty of OCR is not absolute. Besides infant relapsing fainting
pells with VHR may be treated by atropinic drugs [8]. We
hought that complementary biochemical tests exploring the
ympathetic and parasympathetic nervous systems would
e welcome for the diagnosis, the follow-up under treat-
ent and a better comprehension of the physiopathology
f VHR. Since noninvasive, urinary tests are preferred in
nfants.
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In a previous experimental study, we observed a decrease
n norepinephrine (NE) urinary excretion (U) in rats with
xperimental vagal hypertonia induced by reserpine. Oppo-
ite variations were found in a model of vagal hypotonia
nduced by diphemanil-methylsulfate [9].
We therefore determined UNE, but also U epinephrine (E)
nd U dopamine (D) in infants with fainting spells who were
ested for VHR.
ubjects and methods
ubjects
ifty-ﬁve infants from 0.5 to 11months of age were
nvestigated at the ‘‘Centre de cardiologie infantile du
hâteau-des-Côtes’’ for VHR, 51 after fainting spells, four
s siblings of SIDS victims. The investigation includes rou-
inely, besides the history and the clinical examination, OCR
nd 24-h Holter ECG [6]. At the end of the evaluation, diag-
osis was established, ranging from frank VHR (score 4) to
bsence of VHR (score 1). Positive diagnosis of VHR (score 4)
s admitted in the presence of one major criterium, or three
inor criteria. Possible VHR (score 3) or doubtful VHR (score
) are considered in the presence of two minor criteria or
ne minor criterion respectively.
Major criteria:
fainting or syncope during the Holter ECG monitoring with
a simultaneous prolonged sinus pause;
inducibility of fainting or syncope during OCR reproducing
the same type of faint described by the family.
Minor criteria:
history of familial VHR;
identiﬁcation of vagally mediated signs induced by factors
like pain, vomiting, crying;
clinical symptoms such as pallor, hypotonia, cyanosis of
the lips;
positive OCR test or indexes of VHR on the Holter record-
ing.
The study complied with the Helsinki declaration. After
nformed and written consent of the parents, as recom-
ended by Huriet Law, two consecutive noninvasive urinary
ollections were carried out. A urinary bag was installed for
3-h collection starting between 9 h and 10 h 30 a.m. just
fter the clinical examination and the OCR test; then a 21-
collection followed immediately and covered the whole
ight period. Results for 24 h were obtained by calculation.
his protocol was established to test the diagnostic value of
he 3-h versus the 24-h collection.
lectrophysiological cardiac parameters
he quantitative parameters of OCR were studied as in
5,6,10]:
minimum heart rate (FminOCR), calculated on three suc-
cessive beats, expressed as beats per minute (bpm);
RRmaxOCR (maximum interval between two R waves, in
ms);
FiOCR, percentage of heart rate (HR) deceleration:
◦ Fi = [(HR before the test — HR during the test)/HR
before the test]× 100.
l
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Evident VHR criteria under 3months are:
minOCR ≤ 50 bpm, RRmaxOCR ≥ 1200ms or FiOCR ≥ 66%.
Moderate VHR criteria under 3months are:
minOCR ≤ 75 bpm, RRmaxOCR ≥ 800ms or FiOCR ≥ 50%.
The Holter quantitative parameters were [4,6]:
FminHolter, minimum cardiac frequency observed during
the 24 h (in bpm);
FiHolter, maximal deceleration upon 10 s, observed during
the 24 h.
VHR criteria are FminHolter ≤ 80 bpm under 1month,
70 bpm under 2months, ≤ 60 bpm between 2months and
year, or FiHolter ≥ 55% or FiHolter ≥ 100 bpm absolute
eceleration.
rinary collection and biochemical assays
rine collection was carried out after addition of 0.5mL
f HCl for 3 h and 2mL for 21 h in the storage bottles,
ept at 4 ◦C during the collection and frozen at −30 ◦C
hereafter. Urine acidity was checked (pH between 1 and
).
Total norepinephrine, epinephrine and dopamine
free and conjugated) were measured by high per-
ormance liquid chromatography (HPLC) in reverse
hase with amperometric electrochemical detection,
fter hydrolysis (20min at 80 ◦C, at a pH of 0.8 to 1)
nd extraction by ionic exchange on Biorad column
9].
Creatinine (Cr) was determined by the Jaffé method on
ONE ‘‘Optima’’ analyzer. The ﬁrst 20 samples were mea-
ured with and without previous pH neutralization. The
esults obtained were similar. Therefore pH neutralization
as omitted further on.
All results of biochemical assays of catecholamines were
xpressed as nmol per mmol Cr.
tatistical methods
n the whole group infants from 0.5 to 11months
r in different groups of age, the urinary excre-
ions of the different catecholamines are represented
y the mean± SD and/or the (range). Loge of the
alues was used to normalize their distribution if neces-
ary.
For studying correlations between urinary excretion of
ach catecholamine and A37 age or electrocardiographic
arameters, Pearson’s correlation as well as multiple
orrelation coefﬁcients were determined, using the sta-
istical Analysis System SAS 9.2 software (SAS Institute
nc, Cary, NC, USA) with the CORR procedure; adjust-
ent for age was effected by the REG procedure (0
f ≤ 3months, 1 if > 3months, since 3months of age
as been found to be a critical milestone, see discus-
ion).
For studying the variations of excretion of each metabo-
ite in function of age (age sections of 1month) or collection
ime (3 h/21 h) or VHR score (1 to 4), analysis of variance was
sed, followed by comparison of means by the Bonferoni-
tudent t test.
The level of signiﬁcance was considered as P≤ 0.05.
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Results
Clinical characteristics of the infants
Age
Out of 55 infants, six were under 1month (0.5 to
0.9months), 15 from 1.0 to 1.9months, 18 from 2.0 to
2.9months, eight from 3.0 to 3.9months, three from 4.0 to
4.9months, ﬁve older than 5months (5.3, 7.6, 9.5, 10, 10.3).
Five children were preterms, (30 to 36weeks). Maturation
of the cardiac control being in relation with the gestational
age [11], we used for these children an A37 age, as if they had
been born at 37weeks. Eighty-ﬁve percent of the children
had their ﬁrst fainting spell before 3months of age.
Diagnosis of VHR
Sixteen children had positive VHR (score 4), 15 possible VHR
(score 3), nine doubtful VHR (score 2), 15 absence of VHR
(score 1). None of the four siblings of SIDS victims had VHR.
Urinary epinephrine
Variations of excretion in function of age or
collection time
For the infants of all ages, the mean
UE24h = 14.8± 10.1 nmol/mmolCr (with high individual
variations, from 1 to 43.8 nmol/mmolCr). In contrast with
norepinephrine excretion (see below), neither UE24h nor
LogUE24h were correlated with the A37 age (r = 0.077 and
r = 0 respectively).
C
W
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Table 1 Correlations between urinary catecholamine excreti
reﬂex dynamic testing and 24-hour Holter recording in infants
Correlation coefﬁcient
conﬁdence interval)
ECG variables RRmax, ms Fmi
During oculo-cardiac reﬂex test
Epinephrine (Log nmol/mmolCr) −0.34 (−0.55;
−0.08)**
0.31
0.54
Norepinephrine (Log nmol/mmolCr) −0.25 (−0.49;
0.02)a
0.19
0.43
Dopamine (nmol/mmolCr) 0.02 (−0.25;
0.28)
−0.
0.23
During 24-hour Holter recording
Epinephrine (Log nmol/mmolCr) — 0.16
0.41
Norepinephrine (Log nmol/mmolCr) — 0.11
0.36
Dopamine (nmol/mmolCr) — −0.
0.25
Urinary vanillymandelic acid and homovanillic acid were also determ
variables during oculocardiac reﬂex testing or 24-hour Holter recording
bpm: beats per minute; ECG: electrocardiogram; Fi: percentage o
maximum interval between two R waves. *P≤ 0.05; **P≤ 0.02; ***P≤ 0
a Marginal signiﬁcance (0.06 ≤ P≤ 0.10).433
For what concerns the effect of collection time, UE21h was
ower than UE3h only in children aged less than 2months
8.7± 5.6 nmol/mmolCr vs 24.4± 24.2 nmol/mmolCr,
< 0.005). Beyond 2months of age, the difference
isappeared.
orrelations with OCR ECG parameters
n all children between 0.5 and 11months, LogUE24h was
egatively correlated with RRmaxOCR (r =−0.34; P = 0.012),
ositively correlated with FminOCR (r = +0.31; P = 0.024),
arginally correlated with FiOCR (r =−0.24; P = 0.084)
Table 1).
When adjusted for age, the previous correlations were
ot markedly modiﬁed (for example, P = 0.014, instead
f P = 0.012, for the correlation between LogUE24h and
RmaxOCR).
When the three OCR ECG parameters used for the diag-
osis of VHR were taken together in a multiple correlation,
ogUE24h was highly correlated with the three parameters
r = |0.36|; P = 0.009).
Fig. 1 shows the individual results for RRmaxOCR
nd the correlation curve obtained. The latter
hows that when RRmaxOCR is greater or equal to
00ms, LogUE24h tends to be less or equal to 2.2
nd consequently UE24h tends to be less or equal to
nmol/mmolCr.orrelations with Holter ECG parameters
e found no correlation between LogUE24h and the Holter
CG parameters, whatever the age (Table 1).
ons and electrocardiogram variables during oculocardiac
with fainting episodes, aged between 0.5 and 11 months.
r (95% Multiple correlation
coefﬁcient r
n, bpm Fi (%) RRmax, Fmin and Fi
(0.04;
)*
−0.24 (−0.47;
0.03)a
|0.36|***
(−0.08;
)
−0.11 (−0.37;
0.16)
|0.33|**
04 (−0.30;
)
0.10 (−0.17;
0.36)
|0.17|
(−0.11;
)
−0.13 (−0.39;
0.16)
—
(−0.17;
)
0.12 (−0.17;
0.39)
—
02 (−0.29;
)
0.22 (−0.07;
0.47)
—
ined, but no signiﬁcant correlations were found with the ECG
.
f heart rate deceleration; Fmin: minimum heart rate; RRmax:
.01.
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Figure 1. A. Correlation between Loge (epinephrine) and RRmax on ECG recording during oculocardiac reﬂex for detecting vagal hyper-
reactivity, in infants with fainting spells (0.5 to 11months old). r =−0.34; P = 0.012. B. Correlation between Loge (norepinephrine) and
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pRmax on ECG recording during oculocardiac reﬂex for detecting
ld). r =−0.25; P = 0.06. Loge (norepinephrine) was signiﬁcantly co
deceleration) taken together in a multiple correlation (r = |0.33|;
tudies of correlations with UE3h
tudies of correlations with UE3h were unsuccessful, partly
ecause of the great variability of spontaneous urine collec-
ion volume, during this short period. The same will apply
or UNE3h and UD3h.
rinary norepinephrine
ariations of excretion in function of age or
ollection time
or all the infants aged from 0.5 to 11months, the
ean UNE24h was 229± 104 nmol/mmolCr (30.0 to
68 nmol/mmolCr); UNE24h was correlated with the A37
ge (r =−0.26, P = 0.05); LogUNE24h was more tightly
orrelated with the A37 age (r =−0.30, P = 0.027).
I
n
o
Pl hyperreactivity, in infants with fainting spells (0.5 to 11months
ed with the three OCR ECG parameters of VHR (RRmax, Fmin and
015).
UNE24h was higher in infants under 3months
259± 107 nmol/mmolCr) than in infants greater or
qual to 3.0months (179± 94 nmol/mmolCr), P < 0.005.
For what concerns the effect of collection time, in
he children under 3months, UNE21h was lower than UNE3h
248± 70 vs 408± 197 nmol/mmolCr, P < 0.001). Beyond
months, the signiﬁcance of the difference disappeared
180± 100 vs 211± 105 nmol/mmolCr).
orrelations between UNE24h and OCR ECG
arameters
n all the infants from 0.5 to 11months, LogUNE24h was sig-
iﬁcantly correlated with the three OCR ECG parameters
f VHR taken together in a multiple correlation (r = |0.33|;
= 0.015) (Table 1).
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When the OCR ECG parameters were considered sepa-
rately, LogUNE24h was marginally correlated with RRmaxOCR
(r =− 0.25; P = 0.06), but not correlated signiﬁcantly either
with FminOCR (r = +0.19; P = 0.17) or with FiOCR (r =−0.11;
P = 0.41).
When adjusted for age, the previous correlations were
not markedly modiﬁed.
Fig. 1 shows the individual results for RRmaxOCR and
the correlation curve obtained. The latter shows that when
RRmaxOCR is greater or equal to 800ms, LogUNE24h tends to
be less or equal to 5.24 and UNE24h tends to be less or equal
to 190 nmol/mmolCr.
Correlations between UNE24h and Holter ECG
parameters
No correlation was found between LogUNE24h and FminHOLTER
or Fi HOLTER (Table 1).
Urinary dopamine
Variations of excretion in function of age or
collection time
For the infants of all ages, the mean
UD24h = 2651± 1063 nmol/mmolCr (77 to
6190 nmol/mmolCr). UD24h/Cr did not vary signiﬁcantly
with age. UD21h/Cr was lower than UD3h/Cr until 3months
of age, the difference reaching signiﬁcance in children
between 2 and 3months (P < 0.025).
Correlations with OCR ECG parameters
In all the infants from 0.5 to 11months, UD24h was not corre-
lated with RRmax (P = 0.90), with FminOCR (P = 0.76) or with
FiOCR (P = 0.47) (Table 1).
Correlations with Holter ECG parameters
No signiﬁcant correlation was found between UD24h and
FminHOLTER (P = 0.88) or Fi HOLTER (P = 0.13) in the infants
from 0.5 to 11months (Table 1).
Discussion
The various studies previously published about the uri-
nary excretion of the different catecholamines in children
aimed essentially at establishing normal ranges to track
down neuroblastomas [12—17]. In this prospect, the authors
sought essentially to establish higher limits. No lower lim-
its were generally given. For each catecholamine studied,
our results are in agreement with those previously pub-
lished. We also conﬁrmed a strong interindividual variability.
To our knowledge, no study described the evolution of
catecholamine urinary excretion in infants under 1 year.
Decrease of UNE/Cr after 3months has not been reported.
The circadian differences we observed (higher excre-
tions in the morning during the 3-h collection, before
3months for NE and D and before 2months for E) had
not been described before. We must notice that the
morning time collection corresponded, in our study, to
a period of stress: clinical examination, OCR, setting of
Holter electrodes and urinary bag. Besides, one must
o
a
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ecall that the infants studied here had presented fainting
pell(s).
Our study of the correlations between the quantitative
rinary excretion of cathecholamines and quantitative ECG
arameters in infants with fainting spell(s), is in fact inde-
endent of the qualitative diagnosis of VHR in the various
ndividuals, which may be sometimes difﬁcult (in case of
cores 2 or 3: possible or doubtful VHR). The ECG parame-
ers measured during the OCR were generally found to be
ore strongly correlated with urinary excretion of cathe-
holamines than the ECG parameters measured on the
olter recording.
UE24h was negatively correlated with VHR intensity, as
easured by OCR ECG parameters. Indeed, in the case of
rank VHR, FminOCR decreases, RRmax and FiOCR increase.
n this situation, we generally observed a diminution of UE.
hen UE24h is less or equal to 9 nmol/mmolCr, RRmax tends
o be greater or equal to 800ms (Fig. 1) and Fmin less or
qual to 70 bpm. Low UE could be a useful auxiliary marker
or VHR.
UNE24h was also negatively correlated with VHR inten-
ity as represented by the three OCR ECG parameters taken
ogether and also particularly by RRmaxOCR alone. If UNE24h is
ess or equal to 190 nmol/mmolCr, RRmax tends to be greater
r equalt to 800ms. Low UNE24h could be another marker for
HR.
These results suggest the possible contribution of sympa-
hetic hypotonia and/or adrenomedullary hyposecretion in
he physiopathology of faintings associated with VHR.
Our ﬁndings are in accordance with our previous exper-
mental observations [9]: diminution of UNE in rats with
harmacological parasympathetic hypertonia (−44%) and
ncrease in UNE in rats with parasympathetic hypoactivity
+61%).
At the critical age of 3months, UNE24h decreases and its
igniﬁcant circadian modiﬁcations tend to disappear in our
tudy. At the same period, heart rate starts to diminish,
ith a more signiﬁcant reduction during daytime [18]. In
his study, the age of 71% of the infants was less or equal to
.9months, that of 15% between 3 and 3.9months; 85% of
he infants had their ﬁrst fainting spell before 3.0months of
ge. Moreover, SIDS incidence curve shows a peak at about
months. SIDS may be related to VHR. Several cases of SIDS
ere observed in infants having noradrenergic deﬁcits [19];
hese deﬁcits were alterations of catecholaminergic neurons
20—22], alterations in catecholamine enzymes [21,23,24]
r alterations in alpha2-adrenergic receptors [25].
For what concerns the possible use of UE24h and UNE24h
s markers for VHR, it must be stressed that it is difﬁcult to
etermine their sensitivity and speciﬁcity since the diagnosis
f VHR is greatly clinical. Another difﬁculty is due to the
xistence of three classes of infants: one class of infants with
ositive VHR (28% of the infants with score 4), one class with
bsent VHR (28% of the infants with score 1), but also a third
lass with uncertain VHR (44% of the infants with possible
r doubtful VHR corresponding to scores 3 or 2); the latter
lass, which represents almost one half of the whole group
f infants, cannot be used for determining a sensitivity and
speciﬁcity.
In our study, UE24h appeared as a more promising marker
han UNE24h. In the infants from 0.5 to 11months, the mean
ogUE24h was 2.74, 2.29 and 2.20 (corresponding to UE24h of
41
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[36
5.5, 9.9 and 9.0 nmol/mmolCr) for scores 1, (2 + 3) and 4
espectively (not signiﬁcant). At the critical age between 1
nd 3months, the mean LogUE24h was 2.73, 2.28 and 2.04
corresponding to UE24h of 15.3, 9.8 and 7.7 nmol/mmol Cr)
or scores 1, (2 + 3) and 4 respectively (not signiﬁcant); how-
ver at this critical age, 50% of infants with score 4 had a
E24h less or equal to 9 nmol/mmolCr whereas no infant with
core 1 had a UE24h less or equal to 9 nmol/mmol Cr. A more
xtensive study is necessary to test the interest of UE24h and
NE24h as markers for VHR.
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